Navigation Links
Hepatitis B Virus Surface Antigen, Confirmation

ProductsHepatitis B Virus Surface Antigen, Confirmation
Company ARUP Laboratories
Item Hepatitis B Virus Surface Antigen, Confirmation
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. NOW® Hepatitis B Test
2. Autoimmune Hepatitis Panel Pluswith Reflex to Titers
3. Autoimmune Hepatitis Panelwith Reflex to ANA IFA Titer
4. Hepatitis A Virus Antibodies (Total)
5. Hepatitis A Virus Antibody, IgM
6. Hepatitis A Virus Panel
7. Hepatitis B Virus DNA Ultrasensitive Quantitative Real-Time PCR
8. Hepatitis B Virus Surface Antibody
9. Hepatitis B Virus Core Antibodies (Total)
10. Hepatitis B Virus Surface Antigenwith Reflex to Confirmation
11. Hepatitis B Virus Core Antibody, IgM
...assessment using Fractional Flow Reserve (FFR) is ...for determining the functional,degree and locati...5,Sensor and RadiAnalyzer Xpress offer fast, eas...ing a new level of certainty to clinical decision-...
...ivid 7 Dimension cardiovascular ultrasound system ... first fully integrated real-time 4D and multi-dim...on, a latest member of the Vivid 7 family, provide...nosing heart conditions such as heart failure in p...
...eeper Lesions ,Designed for the treatment of...eezor MAX is a powerful ablation-only catheter. Th...designed to provide maximum cryo performance. It i...ryocatheters, but its larger shaft and ablation ti...
... series represents a breakthrough that makes nonin...s revolutionary design integrates Quantum 64-row d...d advanced software. In fact, Aquilion CFX sets a... a sensitivity of 88% and specificity of 91% in de...
Medicine Products:
(Date:12/4/2008)...11,000 people raced to wellness in Louisiana Stat...The health challenge event was the latest in a ser...na which began in 2004 and is part of a growing mo...s North America. , No longer one of the country...e a leader with innovative programs and new wellne...
(Date:12/4/2008)...e survey of medical professionals, 38 physician-sc...Institute at Harbor-UCLA Medical Center (LA BioMed... Super Doctors, according to the December issue of... Inc. conducted a survey of more than 30,000 medic...ern California Super Doctors for Los Angeles magaz...
(Date:12/4/2008)...re-USNewswire/ -- AARP CEO Bill Novelli today rele...test Congressional efforts to help failing industr...-bin/prnh/20070209/NYF043LOGO ) , , "We ar...if we allow America,s biggest automakers to fail. ...porations go under -- taking with them the men and...
(Date:12/4/2008)...stCall/ -- SurgiCount Medical,Inc., a division o...Board:,PSTX), today announced that it has joined ...ners in helping to create a safer, higher quality ...nsor at Leapfrog,s next two meetings in,December ...ivileged to enter into an affiliation with,Leapfr...
Breaking Medicine News(10 mins):Health News:High Tech Wellness Inspires Louisiana 2Health News:LA BioMed researchers among Southern California Super Doctors 2Health News:AARP: Health Care and Pension Reform Critical to Economic Recovery 2Health News:AARP: Health Care and Pension Reform Critical to Economic Recovery 3Health News:SurgiCount Medical Joins The Leapfrog Group 2
...men who had suffered from postpartum depression an...g able to lose weight. A new study by scientists o... tells that it is possible to lose weight and stil...r a long time antidepressants to be taken for post...
...tration (FDA) of US had warned the public and medi...roadly called as atypical antipsychotic drugs on e...zole, olanzapine, quetiapine, risperidone, clozapi...he clinical treatment of schizophrenia and mania. ...
...ennium Ecosystem Assessment, scientists have said ... are having a detrimental effect to human health a...es such as malaria and cholera are threatening to ...s are emerging because of 60% of the beneficial fa...
...8 diabetic patients and 799 non-diabetic women vol...s of Epidemiologic Research and Information Center...es the risk of having a urinary tract infection fo...The researchers have done two annual follow up of ...
Other Medicine News:
(Date:12/3/2008)...irstCall/ -- Isis Pharmaceuticals,Inc. (Nasdaq: ...icals, Inc.,provided positive survival results fr... in combination with docetaxel and prednisone ("th...one alone ("the control arm") for first-line,trea...ncer. The current 10.6,month median overall surv...
(Date:12/2/2008)...irstCall/ -- Biopure Corporation,(Nasdaq: BPUR ...arch Center,(NMRC) has submitted to the Food and ...al new drug (IND) application to conduct a clinica...ure(R) [hemoglobin glutamer - 250 (bovine)],for t...tients. The study is,entitled "Operation Restore ...
(Date:12/1/2008).../ -- New research has found that the availability ... scanner in an emergency room can significantly in...potentially life-saving treatment. Results of the ...MC)-Salem Hospital in Salem, Mass., will be presen...l Society of North America (RSNA). , , "The...
(Date:12/1/2008)...oche announced today that a,comparative study con...nd,discomfort associated with blood glucose testi...ems and lancing devices were deemed least painful....U-CHEK Aviva and ACCU-CHEK Compact,Plus blood glu...x, ACCU-CHEK,Softclix and ACCU-CHEK Softclix Plus...
Breaking Medicine Technology:Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 2Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 3Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 4U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 2U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 3Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3Casey Family Programs Hires Ken Patterson as Managing Director of Child and Family Services 6515 1Casey Family Programs Hires Ken Patterson as Managing Director of Child and Family Services 6515 2Blue Cross and Blue Shield of Oklahoma Announces Flexible Affordable Blue MedicareRx 28SM 29 Medicare Prescription Drug Plans 6512 1Blue Cross and Blue Shield of Oklahoma Announces Flexible Affordable Blue MedicareRx 28SM 29 Medicare Prescription Drug Plans 6512 2Live Christmas Trees Can Trigger Mold Allergies 6510 1Live Christmas Trees Can Trigger Mold Allergies 6510 2Live Christmas Trees Can Trigger Mold Allergies 6510 3Geisinger rheumatologists redesign osteoporosis rheumatoid arthritis care 6507 1Geisinger rheumatologists redesign osteoporosis rheumatoid arthritis care 6507 2
...BUSINESS WIRE)--Jun 12, 2007 - Proprietary Pulsed,... by Ivivi,Technologies, Inc. (AMEX:II), improved n...brain inflammation, researchers,reported today in ... Society (BEMS,http://www.bioelectromagnetics.org... is associated with neuron death that occurs in,Pa...
...on of Phase II Study Demonstrates Significant,Addi...NGTON, Mass., June 12, 2007 /PRNewswire-FirstCall/...that results from the,Company,s Phase II EXPRESS t...ttering will be presented today at the 47th annual...(NCDEU), sponsored,by National Institute for Menta...
Other Medicine Technology:Ivivi's PEMF Technology Significantly Improves Neuron Survival in,Parkinson's Disease Model, Study Finds 2Ivivi's PEMF Technology Significantly Improves Neuron Survival in,Parkinson's Disease Model, Study Finds 3Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 2Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 3Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 4Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 5Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 6Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 7Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 8Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 9